Wed. Oct 5th, 2022
Cipla partners Premier Medical Corporation to launch COVID-19 rapid antigen test kits in India “In this collaboration, Cipla will be responsible for the marketing and distribution of the Rapid Antigen Detection Test for the qualitative detection of SARS-CoV-2 antigen that will be manufactured by Premier Medical Corporation Pvt Ltd,” Cipla said in a regulatory filing.